BEN
57
11
ALL
41
-3
CMS
57
-3
ABBV
55
-4
CME
48
2
BRK.B
33
-3
COF
53
-9
C
81
-3
A
60
-2
AA
57
-7
CMA
73
-2
CSX
44
-13
DE
58
-4
AIZ
69
-2
AAPL
45
-3
CFG
89
-4
CCL
77
-5
AME
57
-2
AN
58
-2
CPB
25
-2
BEN
57
11
ALL
41
-3
CMS
57
-3
ABBV
55
-4
CME
48
2
BRK.B
33
-3
COF
53
-9
C
81
-3
A
60
-2
AA
57
-7
CMA
73
-2
CSX
44
-13
DE
58
-4
AIZ
69
-2
AAPL
45
-3
CFG
89
-4
CCL
77
-5
AME
57
-2
AN
58
-2
CPB
25
-2
Financhill
Back

MaxCyte Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Sell
48

MXCT
MaxCyte

Last Price:
$2.23
Seasonality Move:
25.9%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

MaxCyte Stock Forecast

  • Is MaxCyte Stock Undervalued?
    The current MaxCyte [MXCT] share price is $2.24. The Score for MXCT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • MXCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will MaxCyte Stock Go Up Next Year?

Data Unavailable

MaxCyte Stock Rating

Data Unavailable

MaxCyte Stock Price History

Is MXCT stock going to rise?

  • The current trend is relatively stagnant and MXCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
maxcyte.com

52-Week Data

52-Week High:
5.20
52-Week Low:
2.00

Prediction Charts

Market Cap:
237.6M
Price in USD:
2.24
Volume:
161.3K
Beta:
0.22

Technical Analysis

SMA50:
2.37
SMA100:
2.80
SMA200:
3.40
52-Wk Change:
-40.56%

Stock Predictions

  • Is MaxCyte stock public?
    Yes, MaxCyte is a publicly traded company.
  • What is the MaxCyte stock quote today?
    The MaxCyte stock price is 2.24 USD today.
  • How to buy MaxCyte stock online?
    You can buy MaxCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-16 2.22 2.24 2.28 2.20
Jun-17 2.21 2.15 2.26 2.15
Jun-18 2.15 2.11 2.18 2.10
Jun-20 2.11 2.04 2.12 2.03
Jun-23 2.02 2.17 2.19 2.01
Jun-24 2.19 2.22 2.26 2.13
Jun-25 2.10 2.23 2.28 2.00
Jun-26 2.23 2.30 2.32 2.19
Jun-27 2.31 2.20 2.31 2.17
Jun-30 2.21 2.18 2.25 2.16
Jul-1 2.15 2.17 2.25 2.13
Jul-2 2.18 2.24 2.27 2.15
Jul-3 2.24 2.24 2.30 2.22
Jul-7 2.20 2.17 2.27 2.16

MaxCyte Earnings

Data Unavailable

MaxCyte Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.04 per share, and an increase next year of $0.02 per share.

* MaxCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.